• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管活性肠肽在实验性自身免疫性脑脊髓炎期间诱导调节性T细胞。

Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis.

作者信息

Fernandez-Martin Amelia, Gonzalez-Rey Elena, Chorny Alejo, Ganea Doina, Delgado Mario

机构信息

Institute of Parasitology and Biomedicine, CSIC, Granada 18100, Spain.

出版信息

Eur J Immunol. 2006 Feb;36(2):318-26. doi: 10.1002/eji.200535430.

DOI:10.1002/eji.200535430
PMID:16402407
Abstract

CD4(+)CD25(+) regulatory T cells (Treg) control the immune response to a variety of antigens, including self-antigens. Several models support the idea of the peripheral generation of CD4(+)CD25(+) Treg from CD4(+)CD25(-) T cells. Little is known about the endogenous factors and mechanisms controlling the peripheral expansion of CD4(+)CD25(+) Treg. In this study we report on the capacity of the vasoactive intestinal peptide (VIP), an immunosuppressive neuropeptide, to induce functional Treg in vivo during the development of experimental autoimmune encephalomyelitis (EAE), a multiple sclerosis model. The administration of VIP to EAE mice results in the expansion of the CD4(+)CD25(+), Foxp3-expressing T cells in the periphery and the nervous system, which inhibit encephalitogenic T cell activation. In addition to the increase in the number of CD4(+)CD25(+) Treg, VIP induces more efficient suppressors on a per cell basis. The VIP-generated CD4(+)CD25(+) Treg transfer suppression and significantly ameliorate the progression of the disease.

摘要

CD4(+)CD25(+)调节性T细胞(Treg)控制对多种抗原(包括自身抗原)的免疫反应。几种模型支持从CD4(+)CD25(-)T细胞外周生成CD4(+)CD25(+)Treg的观点。关于控制CD4(+)CD25(+)Treg外周扩增的内源性因素和机制知之甚少。在本研究中,我们报告了血管活性肠肽(VIP)(一种免疫抑制性神经肽)在实验性自身免疫性脑脊髓炎(EAE,一种多发性硬化模型)发展过程中在体内诱导功能性Treg的能力。给EAE小鼠施用VIP会导致外周和神经系统中表达Foxp3的CD4(+)CD25(+)T细胞扩增,从而抑制致脑炎T细胞的激活。除了CD4(+)CD25(+)Treg数量增加外,VIP在每个细胞基础上诱导更有效的抑制细胞。VIP产生的CD4(+)CD25(+)Treg转移抑制并显著改善疾病进展。

相似文献

1
Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis.血管活性肠肽在实验性自身免疫性脑脊髓炎期间诱导调节性T细胞。
Eur J Immunol. 2006 Feb;36(2):318-26. doi: 10.1002/eji.200535430.
2
Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.血管活性肠肽在体内产生CD4+CD25+调节性T细胞。
J Leukoc Biol. 2005 Dec;78(6):1327-38. doi: 10.1189/jlb.0605299. Epub 2005 Oct 4.
3
Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.血管活性肠肽可诱导产生具有治疗胶原诱导性关节炎作用的CD4+、CD25+调节性T细胞。
Arthritis Rheum. 2006 Mar;54(3):864-76. doi: 10.1002/art.21652.
4
Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo: therapeutic applications in autoimmunity and transplantation.血管活性肠肽在体内产生CD4+CD25+调节性T细胞:在自身免疫和移植中的治疗应用。
Ann N Y Acad Sci. 2006 Jul;1070:190-5. doi: 10.1196/annals.1317.011.
5
Paralysis of CD4(+)CD25(+) regulatory T cell response in chronic autoimmune encephalomyelitis.慢性自身免疫性脑脊髓炎中CD4(+)CD25(+)调节性T细胞反应的麻痹
J Neuroimmunol. 2007 Jul;187(1-2):44-54. doi: 10.1016/j.jneuroim.2007.04.004. Epub 2007 May 17.
6
The therapeutic effect of vasoactive intestinal peptide on experimental arthritis is associated with CD4+CD25+ T regulatory cells.血管活性肠肽对实验性关节炎的治疗作用与CD4+CD25+调节性T细胞有关。
Scand J Immunol. 2008 Dec;68(6):572-8. doi: 10.1111/j.1365-3083.2008.02178.x.
7
Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.自然杀伤细胞可阻止CD4+CD25-T淋巴细胞中CD28介导的Foxp3转录。
Exp Hematol. 2007 Mar;35(3):416-25. doi: 10.1016/j.exphem.2006.12.004.
8
Activation of CD4+ CD25+ regulatory T cell suppressor function by analogs of the selecting peptide.选择肽类似物对CD4+ CD25+调节性T细胞抑制功能的激活
Eur J Immunol. 2007 Jan;37(1):139-46. doi: 10.1002/eji.200636577.
9
Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.血管活性肠肽诱导同种异体抗原特异性人调节性T细胞
J Immunol. 2009 Oct 1;183(7):4346-59. doi: 10.4049/jimmunol.0900400. Epub 2009 Sep 4.
10
The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.免疫抑制药物雷帕霉素对小鼠调节性CD4+CD25+Foxp3+T细胞的影响。
Transpl Immunol. 2007 Apr;17(3):153-61. doi: 10.1016/j.trim.2007.01.002. Epub 2007 Jan 24.

引用本文的文献

1
What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson's Disease?炎症能告诉我们哪些关于帕金森病治疗策略的信息?
Int J Mol Sci. 2024 Jan 29;25(3):1641. doi: 10.3390/ijms25031641.
2
Generation of Brain Regulatory T Cells by Co-culturing With Astrocytes.通过与星形胶质细胞共培养产生脑调节性 T 细胞。
Front Immunol. 2022 Jul 15;13:960036. doi: 10.3389/fimmu.2022.960036. eCollection 2022.
3
Tking From Gut to Brain: The Control of Regulatory T Cells Along the Gut-Brain Axis.从肠道到大脑:沿着肠道-大脑轴控制调节性 T 细胞。
Front Immunol. 2022 Jun 30;13:916066. doi: 10.3389/fimmu.2022.916066. eCollection 2022.
4
Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders.利用调节性T细胞的神经保护活性治疗神经退行性疾病。
Mol Neurodegener. 2020 Jun 5;15(1):32. doi: 10.1186/s13024-020-00375-7.
5
Immunotherapy for Parkinson's disease.帕金森病的免疫疗法。
Neurobiol Dis. 2020 Apr;137:104760. doi: 10.1016/j.nbd.2020.104760. Epub 2020 Jan 21.
6
A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases.VIP 轴在炎症和自身免疫性疾病中的应用的临床方法。
Int J Mol Sci. 2019 Dec 20;21(1):65. doi: 10.3390/ijms21010065.
7
Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.系统给予食欲素 A 可通过减轻神经炎症改善实验性自身免疫性脑脊髓炎。
J Neuroinflammation. 2019 Mar 20;16(1):64. doi: 10.1186/s12974-019-1447-y.
8
Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice.垂体腺苷酸环化酶激活多肽(PACAP)可保护小鼠免受米托蒽醌诱导的心脏损伤。
Peptides. 2017 Sep;95:25-32. doi: 10.1016/j.peptides.2017.07.007. Epub 2017 Jul 15.
9
VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.血管活性肠肽1型受体(Vipr1)缺陷小鼠表现出实验性自身免疫性脑脊髓炎症状改善,在效应阶段存在特定缺陷。
J Neuroinflammation. 2016 Jun 29;13(1):169. doi: 10.1186/s12974-016-0626-3.
10
Schistosoma japonicum HSP60-derived peptide SJMHE1 suppresses delayed-type hypersensitivity in a murine model.日本血吸虫热休克蛋白60衍生肽SJMHE1在小鼠模型中抑制迟发型超敏反应。
Parasit Vectors. 2016 Mar 12;9:147. doi: 10.1186/s13071-016-1434-4.